P01.08 Discovery of CRD1601, a potent and selective HPK1 inhibitor with robust in vivo anti-cancer activity

Autor:	S Basu, R Ghosh, D Yadav, M Banerjee, R Shrivastava, A Gautam, A Middya, N Mane, N Rawat, D Pryde, A Surya, S Middya, S Debnath, M Padaliya, S Bano
Jazyk:	angličtina
Rok vydání:	2024
Předmět:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Zdroj:	Journal for ImmunoTherapy of Cancer, Vol 12, Iss Suppl 1 (2024)
Druh dokumentu:	article
ISSN:	2051-1426
DOI:	10.1136/jitc-2024-ITOC10.18
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/6f4fa277235942aab5ceb34796c5d0dc Zobrazit plný text záznamu View record in DOAJ